Brooks Laboratories’ arm gets marketing authorization for Meropenem in Germany

29 Nov 2021 Evaluate

Brooks Laboratories’ subsidiary company -- Brooks Steriscience has received marketing authorisation for antibacterial drug Meropenem in Germany. This is the first marketing authorisation received by the Brooks Steriscience in the European region. Vadodara facility of Brooks Steriscience has received marketing authorisation in Germany for Meropenem.

Brooks Laboratories is a pharmaceutical contract research and manufacturing services company.

Brooks Laboratories Share Price

140.70 -1.15 (-0.81%)
17-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1751.05
Dr. Reddys Lab 1163.70
Cipla 1515.45
Lupin 1936.75
Zydus Lifesciences 831.40
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...